Regarding vitamin D therapy, the 2003 KDOQI guidelines suggest starting therapy with AVD in the CKD stages G3-G4 when the levels of 25(OH)-vitamin D are above 30 ng/mL (75 nmol/L) and the PTH values are higher than the target [13]. Here, PTH is linked to chronic kidney disease.